BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Diagnosis
9 results:

  • 1. Construction and Validation of a Lung cancer Diagnostic Model Based on 6-Gene Methylation Frequency in Blood, Clinical Features, and Serum Tumor Markers.
    Kang C; Wang D; Zhang X; Wang L; Wang F; Chen J
    Comput Math Methods Med; 2021; 2021():9987067. PubMed ID: 34257703
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
    Chen W; Lee Z; Awadallah A; Zhou L; Xin W
    Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
    Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
    BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lifetime exposure to ambient air pollution and methylation of tumor suppressor genes in breast tumors.
    Callahan CL; Bonner MR; Nie J; Han D; Wang Y; Tao MH; Shields PG; Marian C; Eng KH; Trevisan M; Beyea J; Freudenheim JL
    Environ Res; 2018 Feb; 161():418-424. PubMed ID: 29197760
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Quantitative detection of methylation of fhit and BRCA1 promoters in the serum of ductal breast cancer patients.
    Liu L; Sun L; Li C; Li X; Zhang Y; Yu Y; Xia W
    Biomed Mater Eng; 2015; 26 Suppl 1():S2217-22. PubMed ID: 26406001
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Malignant phyllodes tumour of the breast.
    Badar F; Mahmood S; Syed AA; Siddiqui N
    J Ayub Med Coll Abbottabad; 2012; 24(3-4):47-9. PubMed ID: 24669607
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Promoter hypermethylation gene patterns in gynecological tumors].
    Leal Rojas P; Anabalón Rodríguez L; García Muñoz P; Tapia Escalona O; Guzmán González P; Araya Orostica JC; Villaseca Hernández M; Roa Strauch JC
    Med Clin (Barc); 2009 Mar; 132(10):371-6. PubMed ID: 19268989
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Specific 50'CpG island methylation signatures of fhit and p16 genes and their potential diagnostic relevance in Indian breast cancer patients.
    Naqvi RA; Hussain A; Raish M; Noor A; Shahid M; Sarin R; Kukreti H; Khan NJ; Ahmad S; Deo SV; Husain SA; Pasha ST; Basir SF; Shukla NK
    DNA Cell Biol; 2008 Sep; 27(9):517-25. PubMed ID: 18593338
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.